Uncategorized

09 Mar

Uncategorized

EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019

• March 9, 2022
• By admin
• 0 comments

WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / December 17, 2018 / Eastgate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical comp...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives

• March 9, 2022
• By admin
• 0 comments

Key Opinion Leader spreading awareness of diabetes endorses the company’s liquid insulin mouth rinse solution for Type 2 diabetes and p...

Continue reading

09 Mar

Uncategorized

CORRECTED LINK: CEO Anna Gluskin’s interview with Uptick Newswire on 17 October 2018

• March 9, 2022
• By admin
• 0 comments

https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otcpink-etbi/

Continue reading

09 Mar

Uncategorized

CEO Anna Gluskin, Interview with Uptick Network on October 17, 2018

• March 9, 2022
• By admin
• 0 comments

https://upticknewswire.com/wp-content/uploads/2018/10/Uptick-Network-ETBI-Interview-10-17-18.mp3

Continue reading

09 Mar

Uncategorized

CEO Anna Gluskin’s interview-Uptick network 17Oct2018

• March 9, 2022
• By admin
• 0 comments

https://upticknewswire.com/wp-content/uploads/2018/10/Uptick-Network-ETBI-Interview-10-17-18.mp3

Continue reading

09 Mar

Uncategorized

EastGate Biotech Signs Definitive Investment

• March 9, 2022
• By admin
• 0 comments

Non-Dilutive Investment and Product License includes licensing fee and development costs WEST CALDWELL, N.J. and TORONTO, August 27, 2...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Provides Update on investment from Genluiching Mining Corporation

• March 9, 2022
• By admin
• 0 comments

EastGate Biotech Provides Update on investment from Genluiching Mining Corporation.   EastGate to receive the first non-dilut...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Expands Indications of Liquid Insulin Mouth Rinse Solution to Alzheimer’s Disease with Joint Venture Partner Genome Pharmaceuticals

• March 9, 2022
• By admin
• 0 comments

Genome Pharma is the parent company of Netris/Origin BioPharmaceuticals the company’s Joint Venture Partner     WEST CALD...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Unveils Manufacturing Plans in an MOU with Mystic Pharmaceuticals Limited for its Liquid Insulin Mouth Rinse Solution

• March 9, 2022
• By admin
• 0 comments

WEST CALDWELL, NJ and TORONTO, June 21, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company that...

Continue reading

09 Mar

Uncategorized

Morphs into Global Licensing Play with $36 Million in Milestone Payments

• March 9, 2022
• By admin
• 0 comments

EastGate is more than just a drug development company with an oral insulin formulation and an Aging Clinic Surgery Center in Canada. It...

Continue reading